3 European Penny Stocks With Market Caps Under €100M

Tue, Sep 16, 2025, 2:04 AM 4 min read

Amidst rising expectations of a U.S. Federal Reserve rate cut, European markets have shown resilience, with major stock indexes experiencing gains. In this context, the allure of penny stocks—often smaller or newer companies—remains intact as they continue to represent potential growth opportunities for investors seeking alternatives beyond established names. While the term ‘penny stocks’ may seem outdated, their relevance persists when these companies demonstrate financial strength and offer compelling prospects for growth.

Click here to see the full list of 332 stocks from our European Penny Stocks screener.

Let’s take a closer look at a couple of our picks from the screened companies.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Ilkka Oyj, with a market cap of €99.21 million, operates in the publishing and printing sectors both in Finland and internationally through its subsidiaries.

Operations: The company generates revenue from its Marketing and Technology Services segment, amounting to €34.47 million.

Market Cap: €99.21M

Ilkka Oyj, with a market cap of €99.21 million, shows mixed financial health and growth prospects. The company reported strong earnings for the second quarter of 2025, with net income rising significantly to €11.93 million from €3.95 million a year ago, although this was influenced by a large one-off gain of €1.1 million. Despite having more cash than total debt and short-term assets exceeding liabilities, its return on equity remains low at 2.5%. Earnings are expected to decline by an average of 3.7% annually over the next three years, while its dividend yield is not well covered by earnings or free cash flows.

• Unlock comprehensive insights into our analysis of Ilkka Oyj stock in this financial health report.

• Review our growth performance report to gain insights into Ilkka Oyj’s future.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: SHL Telemedicine Ltd. and its subsidiaries offer telemedicine services across Israel, Europe, and other international markets, with a market cap of CHF23.93 million.